Figure 1. Correlation between estrogen receptor (ER), progesterone receptor (PR), and Ki-67 expression in primary breast tumors and synchronous axillary.

Slides:

Advertisements

Similar presentations

TOP2A IS AN INDEPENDENT PREDICTOR OF SURVIVAL IN UNSELECTED BREAST CANCER Amit Pancholi Molecular Profiling of Breast Cancer: Predictive Markers of Long.

Advertisements

Ismail Jatoi, MD, PhD, FACS Dale H. Dorn Chair in Surgery Professor and Chief, Division of Surgical Oncology University of Texas Health Science Center.

AB C Breast cancer Gas6 RNA Seq D E F Figure S1. AXL and GAS6 expression correlates with a mesenchymal signature. (A) Scatter plot representing the RNA.

Geonomics in Breast Cancer Decoding Human Genome Luis Barreras, M.D., FACP.

Discordance in Hormone Receptor and HER2 Status in Breast Cancer during Tumor Progression Lindstrom LS et al. Proc SABCS 2010;Abstract S3-5.

Breast Cancers With Brain Metastases are More Likely to be Estrogen Receptor Negative, Express the Basal Cytokeratin CK5/6, and Overexpress HER2 or EGFR.

Results grade1 grade2 grade3 (1) Can we identify metabolites or metabolic pathways that are associated with breast cancer clinical parameters? Alex-CIS-GCTOF.

Appendix Supplementary data (online only) to: Marleen Kok, Wilbert Zwart, Caroline Holm, Renske Fles, Michael Hauptmann, Laura J. Van ’t Veer, Lodewyk.

First month Second Month First month Second Month Milk line remnant Milk line remnant Accessory axillary breast tissue Accessory axillary breast tissue.

Table S1. Characteristics of breast tumor and normal breast tissue samples. Relevant characteristics of breast tumor and normal breast tissue samples analyzed.

ER and PR Test Estrogen and Progesterone receptor status tests will show whether or not one or both of these hormones fuel the tumor Cancer that is hormone-sensitive.

Breast Cancer Risk with Menopausal Hormone Use Jackie Bouillon Advisor: Dr. Robert Hadley Spring 2007.

Changes in Breast Cancer Reports After Second Opinion Dr. Vicente Marco Department of Pathology Hospital Quiron Barcelona. Spain.

TREATMENT Mastectomy -traditionally, treatment of breast ca has been surgical -19 century, surgical treatment : local excision ~ total mastectomy : radical.

Primary Mets Node Patient 1Patient 2Patient 3 Primary Mets Node Patient 1Patient 2Patient 3 Primary Mets Node Patient 1Patient 2Patient 3 Primary Mets.

Ductal Carcinoma in Situ with Microinvasion: Prognostic Implications, Long-term Outcomes, and Role of Axillary Evaluation Rahul R. Parikh, MD 1, Bruce.

GeneGroupAnalysis BetaCS Alejandro Quiroz-Zárate John Quackenbush lab

Breast Cancer. Breast cancer is a disease in which malignant cells form in the tissues of the breast – “National Breast Cancer Foundation” The American.

NEOPLASIA CASES. CASE 1 A 20 year old female presented with a round mobile breast lump. She has no family history of breast cancer Question : What test.

A B C Supplementary Figure S1. Time-dependent assessment of grade, GGI and PAM50 in untreated patients Landmark analyses of the Kaplan-Meier estimates.

Supplementary Table 1: Clinicopathologic characteristics of 100 patients with invasive breast cancer Clinical characteristicsNumber of cases (%) Median.

Response-Guided Neoadjuvant Chemotherapy for Breast Cancer Gunter von Minckwitz, Jens Uwe Blohmer, Serban Dan Costa, Carsten Denkert, Holger Eidtmann Journal.

Tumor Marker Phenotype Concordance in Second Primary Breast Cancer Monica Brown, MPH, PhD California Cancer Registry Mary Paré, RN, BS Sutter Cancer Center,

Trastuzumab after adjuvant chemotherapy in HER2-positive breast cancer Slideset on: Piccart-Gebhart M, Procter M, Leyland- Jones B, et al. Trastuzumab.

VECTOR 사진자료 Immunoenzymatic Stained Slides. Prostate – Double label. Cytokeratin 5 (m), VECTASTAIN® Universal ABC- AP Kit, Vector® Blue AP substrate (blue).

Date of download: 9/20/2016 From: Breast Cancer in Black Women Ann Intern Med. 1996;124(10): doi: / Age-specific.

Number of brain metastasis

Breast Cancer Risk in Usual Ductal Hyperplasia Is Defined by Estrogen Receptor-α and Ki-67 Expression Abeer M. Shaaban, John P. Sloane, Christopher R.

Fig. 2. Kaplan-Meier curves for survival in each breast cancer molecular subtype. Radiologic assessment in triple-negative breast cancer (A), HER2-positive.

Comparison between Pathologic Characteristics of Her2 Negative and Positive Breast Cancer in a Single Cancer Center in Jordan DR Majdi A. Al Soudi, MD,

Underwriting Breast Cancer

Figure 2. DNA methylation mediated MORT gene silencing is linked to luminal, receptor positive breast cancers. (A) MORT expression level plotted versus.

Figure 3. Representative pyrosequencing results for EGFR gene mutations. (A) Case with 10.9% mutation frequency for the L858R mutation in EGFR exon 21.

Figure 2. A consort diagram showing the flowchart of the trial

Figure 5. Histological specimen of sentinel lymph node after second excision. (A) Histological examination of in situ follicular lymphoma in sentinel lymph.

Figure 1. MORT gene silencing is early event in cancer

Figure 1. Trial profile. From: Efficacy of high-dose alkylating chemotherapy in HER2/neu-negative breast cancer Ann Oncol. 2006;17(4): doi: /annonc/mdl001.

Figure 1 Comparison of tumor size at time of excision between axillary node-negative, axillary node-positive, and distant metastasis subgroups of basal-like.

Supplementary Figure S2

Weight Gain and its Correlates among Breast Cancer Survivors

Benefits of switching postmenopausal women with hormone-sensitive early breast cancer to anastrozole after 2 years adjuvant tamoxifen: Combined results.

徐慧萍1 羅竹君1,2 郭耀隆1 李國鼎1 國立成功大學醫學院附設醫院外科部1 國立成功大學醫學院臨床醫學研究所2

سرطان الثدي Breast Cancer

A B C Supplementary figure S7

Regional lymph nodes and distal extracranial metastases are not a reliable surrogate for actionable mutation in brain metastases. Regional lymph nodes.

Breast Cancer Bone Metastases: It’s All about the Neighborhood

Intraoperative detection of lymph node micrometastasis with flow cytometry in non– small cell lung cancer Manabu Ito, MD, Yoshihiro Minamiya, MD, PhD,

New Views into the Genetic Landscape of Metastatic Breast Cancer

Expression of CD36 and psap in a TMA of human ovarian cancer patients

Estrogen and progesterone receptor expression in patients with uterine smooth muscle tumors Klaus Bodner, M.D., Barbara Bodner-Adler, M.D., Oliver Kimberger,

Computational molecular docking assessment of hormone receptor adjuvant drugs: Breast cancer as an example Sayan Mukherjee, Durjoy Majumder Pathophysiology

Disease-specific survival

Table S1. Inverse correlation between FOXC2 and PP2A/C expression (tested by one-tailed Spearman's nonparametric correlation test, correlation coefficient.

Badwe RA et al. SABCS 2009;Abstract 72.

Overview of the complex interactions among molecular classifications of TNBC based on genomic, transcriptomic, proteomic, epigenomic, and immune characterization.

Intratumoral Heterogeneity of MicroRNA Expression in Breast Cancer

Specificities of Lung Adenocarcinoma in Women Who Have Never Smoked

Programmed Cell Death Ligand (PD-L1) Expression in Stage II and III Lung Adenocarcinomas and Nodal Metastases Hironori Uruga, MD, PhD, Emine Bozkurtlar,

Supplementary Fig S1, Zembutsu H et al.

Refining the Nodal Staging for Esophageal Squamous Cell Carcinoma Based on Lymph Node Stations Jun Peng, MD, Wen-Ping Wang, MD, Ting Dong, MD, Jie Cai,

The antitumor activity of olaparib in PDXs identifies a subset of PARPi‐sensitive tumors The antitumor activity of olaparib in PDXs identifies a subset.

20-Year Risks of Breast-Cancer Recurrence

Justin D Vidal, D. V. M. , Thomas C Register, Ph. D. , Madhu Gupta, Ph

Figure 1. Chloride channel-3 (CIC-3) expression in breast tumor tissues. (A) Chloride channels (ClC-1–7, CFTR) are expressed in human breast cancer tissues.

Figure 4. Effects of chloride channel-3 (ClC-3) knockdown on the expression of cell cycle-regulatory proteins. (A) Representative western blot images of.

Figure 6. Effects of chloride channel-3 (ClC-3) knockdown on the growth of human breast tumors in vivo. (A) Representative images of tumors on day 20 from.

IL6 mRNA is not detected in metastatic prostate cancer cells.

Clustering analysis of DTC-associated genes.

MYC–HOXB7–HER2 predicts clinical outcome in breast cancer patients treated with tamoxifen. MYC–HOXB7–HER2 predicts clinical outcome in breast cancer patients.

Ex vivo imaging of lymph nodes with tumor metastasis using a bioluminescence imaging system. Ex vivo imaging of lymph nodes with tumor metastasis using.

Presentation transcript:

Figure 1. Correlation between estrogen receptor (ER), progesterone receptor (PR), and Ki-67 expression in primary breast tumors and synchronous axillary lymph node metastases. Scatter plot shows breast tumor expression (X-axis) and nodal metastases expression (Y-axis) of ER (A), PR (B) and Ki-67 (C). Strong correlation was observed through Spearman correlation in hormonal receptor and Ki-67 between primary breast tumor and axillary nodal metastases (ER Spearman rho 0.77, p<0.001; PR rho 0.81, p<0.001; and Ki-67 rho 0.72, p<0.001). ERBT=ER percentage in breast tumor; ERNM=ER percentage in nodal metastases; PRBT=PR percentage in breast tumor; PRNM=PR percentage in nodal metastases; KiBT=Ki-67 percentage in breast tumor; KiNM=Ki-67 percentage in nodal metastases. Figure 1. Correlation between estrogen receptor (ER), progesterone receptor (PR), and Ki-67 expression in primary breast tumors and synchronous axillary lymph node metastases. Scatter plot shows breast tumor expression (X-axis) and nodal metastases expression (Y-axis) of ER (A), PR (B) and Ki-67 (C). Strong correlation was observed through Spearman… J Breast Cancer. 2017 Jun;20(2):170-175. https://doi.org/10.4048/jbc.2017.20.2.170